Beatriz Bua-Rey

Salamanca, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Corrigendum to 'A Novel Homozygous Splice-Site Variant in VPS33B Identified as a Cause of Bleeding': [JTHA 24/1, January 2026, Pages 146-154].

Corrigendum to 'A Novel Homozygous Splice-Site Variant in VPS33B Identified as a Cause of Bleeding': [JTHA 24/1, January 2026, Pages 146-154].

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 10, 2026

A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding: reply to the letter to the editor.

A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding: reply to the letter to the editor.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 15, 2026

Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival.

Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival.

Journal: British journal of haematology

Published: February 26, 2026

Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma.

Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma.

Journal: Journal for immunotherapy of cancer

Published: February 25, 2026

Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency.

Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency.

Journal: Thrombosis and haemostasis

Published: December 24, 2025

Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation.

Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 24, 2025

A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding.

A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 25, 2025

Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance.

Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance.

Journal: Blood cancer journal

Published: April 13, 2025

Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients.

Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients.

Journal: HemaSphere

Published: April 10, 2025

Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience.

Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience.

Journal: Cancers

Published: March 22, 2025

Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.

Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.

Journal: American journal of hematology

Published: July 01, 2024

Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma.

Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma.

Journal: Biomedicines

Published: February 26, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026